

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of execution phase of apoptosis (GO:1900118) | 9.20864386 |
| 2 | ribonucleoprotein complex disassembly (GO:0032988) | 7.59741816 |
| 3 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 7.14840673 |
| 4 | organelle disassembly (GO:1903008) | 6.98292549 |
| 5 | glycerophospholipid catabolic process (GO:0046475) | 6.78946221 |
| 6 | cytolysis (GO:0019835) | 6.33125766 |
| 7 | GTP biosynthetic process (GO:0006183) | 6.15053999 |
| 8 | regulation of isotype switching to IgG isotypes (GO:0048302) | 6.09787382 |
| 9 | regulation of tyrosine phosphorylation of Stat5 protein (GO:0042522) | 5.94429296 |
| 10 | parturition (GO:0007567) | 5.57292642 |
| 11 | protein prenylation (GO:0018342) | 5.57098666 |
| 12 | prenylation (GO:0097354) | 5.57098666 |
| 13 | GDP-mannose metabolic process (GO:0019673) | 5.45929737 |
| 14 | UTP biosynthetic process (GO:0006228) | 5.29447218 |
| 15 | behavioral response to nicotine (GO:0035095) | 5.11435401 |
| 16 | L-fucose catabolic process (GO:0042355) | 5.07685540 |
| 17 | fucose catabolic process (GO:0019317) | 5.07685540 |
| 18 | L-fucose metabolic process (GO:0042354) | 5.07685540 |
| 19 | positive regulation of cAMP-mediated signaling (GO:0043950) | 5.04010443 |
| 20 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 4.79209804 |
| 21 | signal peptide processing (GO:0006465) | 4.73765385 |
| 22 | UTP metabolic process (GO:0046051) | 4.70056780 |
| 23 | T cell migration (GO:0072678) | 4.68784427 |
| 24 | platelet dense granule organization (GO:0060155) | 4.66363474 |
| 25 | DNA deamination (GO:0045006) | 4.64609674 |
| 26 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 4.40246299 |
| 27 | cytidine catabolic process (GO:0006216) | 4.33098220 |
| 28 | cytidine deamination (GO:0009972) | 4.33098220 |
| 29 | cytidine metabolic process (GO:0046087) | 4.33098220 |
| 30 | detection of light stimulus involved in sensory perception (GO:0050962) | 4.31091018 |
| 31 | detection of light stimulus involved in visual perception (GO:0050908) | 4.31091018 |
| 32 | positive regulation of isotype switching (GO:0045830) | 4.27575887 |
| 33 | ribosomal small subunit assembly (GO:0000028) | 4.16443327 |
| 34 | regulation of regulatory T cell differentiation (GO:0045589) | 4.10208303 |
| 35 | negative regulation of B cell apoptotic process (GO:0002903) | 4.09381749 |
| 36 | positive regulation of interleukin-17 production (GO:0032740) | 4.05865126 |
| 37 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.01620670 |
| 38 | nucleoside diphosphate phosphorylation (GO:0006165) | 4.01158811 |
| 39 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 3.96117710 |
| 40 | CTP metabolic process (GO:0046036) | 3.93525145 |
| 41 | CTP biosynthetic process (GO:0006241) | 3.93525145 |
| 42 | regulation of execution phase of apoptosis (GO:1900117) | 3.90599708 |
| 43 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.86857704 |
| 44 | positive regulation of DNA recombination (GO:0045911) | 3.68019509 |
| 45 | synaptic transmission, cholinergic (GO:0007271) | 3.66973991 |
| 46 | facial nerve structural organization (GO:0021612) | 3.62313693 |
| 47 | protein refolding (GO:0042026) | 3.50402405 |
| 48 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 3.44005185 |
| 49 | coenzyme A biosynthetic process (GO:0015937) | 3.42294933 |
| 50 | tryptophan catabolic process (GO:0006569) | 3.40641303 |
| 51 | indole-containing compound catabolic process (GO:0042436) | 3.40641303 |
| 52 | indolalkylamine catabolic process (GO:0046218) | 3.40641303 |
| 53 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.35472264 |
| 54 | pyrimidine ribonucleotide biosynthetic process (GO:0009220) | 3.34535752 |
| 55 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 3.34501772 |
| 56 | regulation of metalloenzyme activity (GO:0048552) | 3.31427503 |
| 57 | regulation of activation of Janus kinase activity (GO:0010533) | 3.31169673 |
| 58 | pyrimidine ribonucleoside metabolic process (GO:0046131) | 3.29335597 |
| 59 | phospholipid catabolic process (GO:0009395) | 3.27786759 |
| 60 | pyrimidine ribonucleoside biosynthetic process (GO:0046132) | 3.25675748 |
| 61 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 3.21690342 |
| 62 | lymphocyte chemotaxis (GO:0048247) | 3.19870001 |
| 63 | coenzyme A metabolic process (GO:0015936) | 3.18982320 |
| 64 | fucose metabolic process (GO:0006004) | 3.14905790 |
| 65 | nucleoside diphosphate catabolic process (GO:0009134) | 3.12190330 |
| 66 | regulation of immunoglobulin secretion (GO:0051023) | 3.11993067 |
| 67 | pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208) | 3.10003916 |
| 68 | sleep (GO:0030431) | 3.06952492 |
| 69 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 3.05640968 |
| 70 | pyrimidine ribonucleotide metabolic process (GO:0009218) | 3.04079762 |
| 71 | negative regulation of chemokine production (GO:0032682) | 3.04027183 |
| 72 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.00244627 |
| 73 | cobalamin metabolic process (GO:0009235) | 2.99051214 |
| 74 | negative regulation of phagocytosis (GO:0050765) | 2.98079500 |
| 75 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.97412207 |
| 76 | protein deneddylation (GO:0000338) | 2.95956449 |
| 77 | regulation of cAMP-mediated signaling (GO:0043949) | 2.94565203 |
| 78 | positive regulation of action potential (GO:0045760) | 2.94151115 |
| 79 | cellular ketone body metabolic process (GO:0046950) | 2.90611174 |
| 80 | indolalkylamine metabolic process (GO:0006586) | 2.89558855 |
| 81 | phasic smooth muscle contraction (GO:0014821) | 2.88833906 |
| 82 | nucleoside diphosphate metabolic process (GO:0009132) | 2.88220626 |
| 83 | ketone body metabolic process (GO:1902224) | 2.86980558 |
| 84 | seminiferous tubule development (GO:0072520) | 2.86669348 |
| 85 | kynurenine metabolic process (GO:0070189) | 2.83087300 |
| 86 | positive regulation of protein targeting to membrane (GO:0090314) | 2.81086645 |
| 87 | regulation of tyrosine phosphorylation of STAT protein (GO:0042509) | 2.81069006 |
| 88 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.80991924 |
| 89 | tryptophan metabolic process (GO:0006568) | 2.80957880 |
| 90 | mannose metabolic process (GO:0006013) | 2.79158455 |
| 91 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.78185719 |
| 92 | chemokine-mediated signaling pathway (GO:0070098) | 2.78166930 |
| 93 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.76961930 |
| 94 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.74659977 |
| 95 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.74017725 |
| 96 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.71169594 |
| 97 | positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531) | 2.70497543 |
| 98 | synaptic transmission, dopaminergic (GO:0001963) | 2.67347671 |
| 99 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.66207106 |
| 100 | positive regulation of B cell mediated immunity (GO:0002714) | 2.66207106 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.88016190 |
| 2 | VDR_22108803_ChIP-Seq_LS180_Human | 3.41979203 |
| 3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.18364642 |
| 4 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.18051136 |
| 5 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.98431993 |
| 6 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.97837535 |
| 7 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.97787677 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.77651743 |
| 9 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.52408648 |
| 10 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.44948921 |
| 11 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.26691791 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.19882882 |
| 13 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 2.16074525 |
| 14 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.10453939 |
| 15 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.03610472 |
| 16 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.02443154 |
| 17 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.02122743 |
| 18 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.98793398 |
| 19 | P300_19829295_ChIP-Seq_ESCs_Human | 1.92390357 |
| 20 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.92314206 |
| 21 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.81729016 |
| 22 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.80035867 |
| 23 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.71922024 |
| 24 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.69469316 |
| 25 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.69036169 |
| 26 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.67263083 |
| 27 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.59820417 |
| 28 | NCOR_22424771_ChIP-Seq_293T_Human | 1.59388867 |
| 29 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.58896983 |
| 30 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.56992250 |
| 31 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.56293088 |
| 32 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.52675426 |
| 33 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.52402893 |
| 34 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.51301749 |
| 35 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.50771769 |
| 36 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.48912532 |
| 37 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.48898477 |
| 38 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.43717305 |
| 39 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.39551594 |
| 40 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.38401187 |
| 41 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.33617784 |
| 42 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.33617784 |
| 43 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.33094336 |
| 44 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.33005373 |
| 45 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.30441755 |
| 46 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.30378031 |
| 47 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.29737120 |
| 48 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.29737120 |
| 49 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.29268046 |
| 50 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.26140088 |
| 51 | GATA3_26560356_Chip-Seq_TH2_Human | 1.23305596 |
| 52 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22372000 |
| 53 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.22372000 |
| 54 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.22116109 |
| 55 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.21713769 |
| 56 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.21590136 |
| 57 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.21317963 |
| 58 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.21244788 |
| 59 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.19547783 |
| 60 | MYB_26560356_Chip-Seq_TH1_Human | 1.18971090 |
| 61 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.16902075 |
| 62 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.14446097 |
| 63 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.13744942 |
| 64 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.13190823 |
| 65 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.12766527 |
| 66 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.12524484 |
| 67 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.12408913 |
| 68 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.10776759 |
| 69 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09331539 |
| 70 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07679661 |
| 71 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.07189374 |
| 72 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.07126841 |
| 73 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.06681342 |
| 74 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.06104272 |
| 75 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.05932358 |
| 76 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.04879874 |
| 77 | ERA_21632823_ChIP-Seq_H3396_Human | 1.04641961 |
| 78 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.04492171 |
| 79 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.03393349 |
| 80 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.97245379 |
| 81 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.96827985 |
| 82 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.96254665 |
| 83 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.95932115 |
| 84 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.95626633 |
| 85 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.95413166 |
| 86 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.95327237 |
| 87 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.93576390 |
| 88 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.93282771 |
| 89 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.93005541 |
| 90 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.92910524 |
| 91 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.91600192 |
| 92 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.91600192 |
| 93 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.87213064 |
| 94 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.86363394 |
| 95 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.85769958 |
| 96 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.84965140 |
| 97 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.84491166 |
| 98 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.84482655 |
| 99 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.83899098 |
| 100 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.83471427 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005451_abnormal_body_composition | 4.40905864 |
| 2 | MP0004885_abnormal_endolymph | 4.02673881 |
| 3 | MP0005671_abnormal_response_to | 3.98336572 |
| 4 | MP0001986_abnormal_taste_sensitivity | 3.49710405 |
| 5 | MP0003045_fibrosis | 3.44161200 |
| 6 | MP0001853_heart_inflammation | 3.16783403 |
| 7 | MP0003300_gastrointestinal_ulcer | 3.06620450 |
| 8 | MP0005377_hearing/vestibular/ear_phenot | 3.04096623 |
| 9 | MP0003878_abnormal_ear_physiology | 3.04096623 |
| 10 | MP0003195_calcinosis | 2.73948655 |
| 11 | MP0003879_abnormal_hair_cell | 2.70277538 |
| 12 | MP0003136_yellow_coat_color | 2.69645151 |
| 13 | MP0010368_abnormal_lymphatic_system | 2.56813969 |
| 14 | MP0004510_myositis | 2.51529792 |
| 15 | MP0009785_altered_susceptibility_to | 2.43942338 |
| 16 | MP0001529_abnormal_vocalization | 2.38512974 |
| 17 | MP0000372_irregular_coat_pigmentation | 2.33231325 |
| 18 | MP0001485_abnormal_pinna_reflex | 2.20732588 |
| 19 | MP0002102_abnormal_ear_morphology | 1.99855934 |
| 20 | MP0001835_abnormal_antigen_presentation | 1.97925704 |
| 21 | MP0005171_absent_coat_pigmentation | 1.92022273 |
| 22 | MP0005379_endocrine/exocrine_gland_phen | 1.85879196 |
| 23 | MP0003718_maternal_effect | 1.85779892 |
| 24 | MP0000604_amyloidosis | 1.80951601 |
| 25 | MP0002089_abnormal_postnatal_growth/wei | 1.79870169 |
| 26 | MP0000371_diluted_coat_color | 1.75289821 |
| 27 | MP0005165_increased_susceptibility_to | 1.63122744 |
| 28 | MP0004145_abnormal_muscle_electrophysio | 1.57663594 |
| 29 | MP0010386_abnormal_urinary_bladder | 1.56856034 |
| 30 | MP0002234_abnormal_pharynx_morphology | 1.54098455 |
| 31 | MP0005551_abnormal_eye_electrophysiolog | 1.54052973 |
| 32 | MP0005360_urolithiasis | 1.50781719 |
| 33 | MP0005395_other_phenotype | 1.48979220 |
| 34 | MP0002168_other_aberrant_phenotype | 1.42546772 |
| 35 | MP0003786_premature_aging | 1.39628790 |
| 36 | MP0002735_abnormal_chemical_nociception | 1.36728865 |
| 37 | MP0005025_abnormal_response_to | 1.36316361 |
| 38 | MP0002095_abnormal_skin_pigmentation | 1.33312450 |
| 39 | MP0005310_abnormal_salivary_gland | 1.32468411 |
| 40 | MP0000465_gastrointestinal_hemorrhage | 1.29133159 |
| 41 | MP0002163_abnormal_gland_morphology | 1.27124031 |
| 42 | MP0002733_abnormal_thermal_nociception | 1.27123935 |
| 43 | MP0008872_abnormal_physiological_respon | 1.20798527 |
| 44 | MP0006072_abnormal_retinal_apoptosis | 1.12012298 |
| 45 | MP0001486_abnormal_startle_reflex | 1.11586963 |
| 46 | MP0002751_abnormal_autonomic_nervous | 1.09920881 |
| 47 | MP0000538_abnormal_urinary_bladder | 1.07925433 |
| 48 | MP0005332_abnormal_amino_acid | 1.06921144 |
| 49 | MP0002075_abnormal_coat/hair_pigmentati | 1.03872477 |
| 50 | MP0005166_decreased_susceptibility_to | 1.02536684 |
| 51 | MP0002138_abnormal_hepatobiliary_system | 0.99664860 |
| 52 | MP0005075_abnormal_melanosome_morpholog | 0.99241741 |
| 53 | MP0005408_hypopigmentation | 0.97464685 |
| 54 | MP0001970_abnormal_pain_threshold | 0.96785915 |
| 55 | MP0000049_abnormal_middle_ear | 0.96547464 |
| 56 | MP0008875_abnormal_xenobiotic_pharmacok | 0.96345519 |
| 57 | MP0005645_abnormal_hypothalamus_physiol | 0.95725587 |
| 58 | MP0005174_abnormal_tail_pigmentation | 0.93390389 |
| 59 | MP0001186_pigmentation_phenotype | 0.93104222 |
| 60 | MP0006292_abnormal_olfactory_placode | 0.89527541 |
| 61 | MP0000026_abnormal_inner_ear | 0.89125375 |
| 62 | MP0004484_altered_response_of | 0.88467764 |
| 63 | MP0005595_abnormal_vascular_smooth | 0.88379006 |
| 64 | MP0001968_abnormal_touch/_nociception | 0.85311288 |
| 65 | MP0002693_abnormal_pancreas_physiology | 0.83563479 |
| 66 | MP0002837_dystrophic_cardiac_calcinosis | 0.83043630 |
| 67 | MP0002148_abnormal_hypersensitivity_rea | 0.80410560 |
| 68 | MP0003866_abnormal_defecation | 0.78659318 |
| 69 | MP0003646_muscle_fatigue | 0.77520409 |
| 70 | MP0009745_abnormal_behavioral_response | 0.75745599 |
| 71 | MP0002272_abnormal_nervous_system | 0.75715643 |
| 72 | MP0002876_abnormal_thyroid_physiology | 0.75153714 |
| 73 | MP0001664_abnormal_digestion | 0.75114680 |
| 74 | MP0000613_abnormal_salivary_gland | 0.74976571 |
| 75 | MP0001440_abnormal_grooming_behavior | 0.72487767 |
| 76 | MP0002938_white_spotting | 0.71934031 |
| 77 | MP0008469_abnormal_protein_level | 0.71130796 |
| 78 | MP0001765_abnormal_ion_homeostasis | 0.70926507 |
| 79 | MP0001963_abnormal_hearing_physiology | 0.70034695 |
| 80 | MP0004742_abnormal_vestibular_system | 0.69491916 |
| 81 | MP0004142_abnormal_muscle_tone | 0.68302141 |
| 82 | MP0003448_altered_tumor_morphology | 0.67255707 |
| 83 | MP0008961_abnormal_basal_metabolism | 0.67159251 |
| 84 | MP0001879_abnormal_lymphatic_vessel | 0.66624218 |
| 85 | MP0001958_emphysema | 0.64446732 |
| 86 | MP0002090_abnormal_vision | 0.64006097 |
| 87 | MP0002166_altered_tumor_susceptibility | 0.63270708 |
| 88 | MP0003186_abnormal_redox_activity | 0.62713965 |
| 89 | MP0000427_abnormal_hair_cycle | 0.62027777 |
| 90 | MP0005167_abnormal_blood-brain_barrier | 0.60963024 |
| 91 | MP0000428_abnormal_craniofacial_morphol | 0.60945609 |
| 92 | MP0005636_abnormal_mineral_homeostasis | 0.60734543 |
| 93 | MP0005253_abnormal_eye_physiology | 0.60577048 |
| 94 | MP0001501_abnormal_sleep_pattern | 0.60203866 |
| 95 | MP0003890_abnormal_embryonic-extraembry | 0.59749832 |
| 96 | MP0001293_anophthalmia | 0.59309643 |
| 97 | MP0004019_abnormal_vitamin_homeostasis | 0.59229689 |
| 98 | MP0001764_abnormal_homeostasis | 0.58843720 |
| 99 | MP0000015_abnormal_ear_pigmentation | 0.58507606 |
| 100 | MP0003137_abnormal_impulse_conducting | 0.58484266 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Aplastic anemia (HP:0001915) | 8.15448180 |
| 2 | Homocystinuria (HP:0002156) | 5.65003013 |
| 3 | Abnormality of homocysteine metabolism (HP:0010919) | 5.65003013 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.30567490 |
| 5 | Aplasia/Hypoplasia of the macula (HP:0008059) | 5.12497727 |
| 6 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 4.82611976 |
| 7 | Methylmalonic acidemia (HP:0002912) | 4.80692031 |
| 8 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 4.69894866 |
| 9 | Abnormal rod and cone electroretinograms (HP:0008323) | 4.65680919 |
| 10 | Abnormal auditory evoked potentials (HP:0006958) | 4.08882767 |
| 11 | Methylmalonic aciduria (HP:0012120) | 3.69861556 |
| 12 | Nonprogressive disorder (HP:0003680) | 3.45675034 |
| 13 | Congenital stationary night blindness (HP:0007642) | 3.36990816 |
| 14 | Premature ovarian failure (HP:0008209) | 3.33774340 |
| 15 | Abnormality of methionine metabolism (HP:0010901) | 3.33123941 |
| 16 | Sclerocornea (HP:0000647) | 3.22184154 |
| 17 | Abnormal number of erythroid precursors (HP:0012131) | 3.11927290 |
| 18 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.11388488 |
| 19 | Oral leukoplakia (HP:0002745) | 3.04124004 |
| 20 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 3.02586663 |
| 21 | Abnormality of vitamin B metabolism (HP:0004340) | 3.02584253 |
| 22 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.92987475 |
| 23 | Generalized aminoaciduria (HP:0002909) | 2.80582067 |
| 24 | Hypothermia (HP:0002045) | 2.78637902 |
| 25 | Prostate neoplasm (HP:0100787) | 2.74195272 |
| 26 | Pancytopenia (HP:0001876) | 2.71667160 |
| 27 | Degeneration of anterior horn cells (HP:0002398) | 2.67237881 |
| 28 | Abnormality of the anterior horn cell (HP:0006802) | 2.67237881 |
| 29 | Increased hepatocellular lipid droplets (HP:0006565) | 2.66404325 |
| 30 | Hypoplasia of the fovea (HP:0007750) | 2.63487108 |
| 31 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.63487108 |
| 32 | Palpitations (HP:0001962) | 2.62558837 |
| 33 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.61279093 |
| 34 | T lymphocytopenia (HP:0005403) | 2.58018367 |
| 35 | Acute necrotizing encephalopathy (HP:0006965) | 2.50995532 |
| 36 | Vascular calcification (HP:0004934) | 2.49945348 |
| 37 | Decreased central vision (HP:0007663) | 2.43619713 |
| 38 | Acute encephalopathy (HP:0006846) | 2.42149757 |
| 39 | Lipid accumulation in hepatocytes (HP:0006561) | 2.40070888 |
| 40 | Hepatic necrosis (HP:0002605) | 2.39457651 |
| 41 | Albinism (HP:0001022) | 2.36620657 |
| 42 | Abnormality of T cell number (HP:0011839) | 2.34351635 |
| 43 | Increased intramyocellular lipid droplets (HP:0012240) | 2.30262676 |
| 44 | Hepatocellular necrosis (HP:0001404) | 2.30206352 |
| 45 | Abnormality of T cells (HP:0002843) | 2.29464180 |
| 46 | Abnormality of the fovea (HP:0000493) | 2.25885204 |
| 47 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.25727739 |
| 48 | Dicarboxylic aciduria (HP:0003215) | 2.25727739 |
| 49 | Premature graying of hair (HP:0002216) | 2.22899234 |
| 50 | Mitochondrial inheritance (HP:0001427) | 2.20404657 |
| 51 | Pustule (HP:0200039) | 2.20206947 |
| 52 | Decreased lacrimation (HP:0000633) | 2.17149788 |
| 53 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.16632340 |
| 54 | Mitral stenosis (HP:0001718) | 2.16094354 |
| 55 | Generalized hypopigmentation (HP:0007513) | 2.14790845 |
| 56 | Abnormality of T cell physiology (HP:0011840) | 2.13478579 |
| 57 | Progressive macrocephaly (HP:0004481) | 2.12620043 |
| 58 | Large for gestational age (HP:0001520) | 2.12406732 |
| 59 | Cardiovascular calcification (HP:0011915) | 2.11936483 |
| 60 | 3-Methylglutaconic aciduria (HP:0003535) | 2.10939976 |
| 61 | Cerebral hypomyelination (HP:0006808) | 2.10895816 |
| 62 | Congenital sensorineural hearing impairment (HP:0008527) | 2.10081169 |
| 63 | Protuberant abdomen (HP:0001538) | 2.08652218 |
| 64 | Abnormality of the parathyroid morphology (HP:0011766) | 2.08222082 |
| 65 | Constricted visual fields (HP:0001133) | 2.06789447 |
| 66 | Alacrima (HP:0000522) | 2.06424201 |
| 67 | Orthostatic hypotension (HP:0001278) | 2.05260274 |
| 68 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.04806422 |
| 69 | Abnormality of vitamin metabolism (HP:0100508) | 2.03094576 |
| 70 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 1.98354771 |
| 71 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.97851606 |
| 72 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.97851606 |
| 73 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.97466097 |
| 74 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.97466097 |
| 75 | Microvesicular hepatic steatosis (HP:0001414) | 1.94728766 |
| 76 | Esotropia (HP:0000565) | 1.93754662 |
| 77 | Ventricular fibrillation (HP:0001663) | 1.93636155 |
| 78 | Abnormality of midbrain morphology (HP:0002418) | 1.92643343 |
| 79 | Molar tooth sign on MRI (HP:0002419) | 1.92643343 |
| 80 | Tachypnea (HP:0002789) | 1.90230856 |
| 81 | Increased CSF lactate (HP:0002490) | 1.89720983 |
| 82 | Abnormality of the prostate (HP:0008775) | 1.89227226 |
| 83 | Myokymia (HP:0002411) | 1.87786089 |
| 84 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.85757801 |
| 85 | Increased muscle lipid content (HP:0009058) | 1.85573238 |
| 86 | Prolonged QT interval (HP:0001657) | 1.85008977 |
| 87 | Dysautonomia (HP:0002459) | 1.83251763 |
| 88 | True hermaphroditism (HP:0010459) | 1.78886964 |
| 89 | Metaphyseal dysplasia (HP:0100255) | 1.78699775 |
| 90 | Macrocytic anemia (HP:0001972) | 1.76557490 |
| 91 | Menstrual irregularities (HP:0000858) | 1.75292493 |
| 92 | Wide intermamillary distance (HP:0006610) | 1.74720780 |
| 93 | Furrowed tongue (HP:0000221) | 1.69725827 |
| 94 | Microcytic anemia (HP:0001935) | 1.69620412 |
| 95 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.68978019 |
| 96 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.68804700 |
| 97 | Lethargy (HP:0001254) | 1.68498078 |
| 98 | Hypoproteinemia (HP:0003075) | 1.66684781 |
| 99 | Severe combined immunodeficiency (HP:0004430) | 1.66091326 |
| 100 | Thyroiditis (HP:0100646) | 1.66085771 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 4.09728848 |
| 2 | ADRBK2 | 3.29139222 |
| 3 | BCKDK | 2.77401731 |
| 4 | CLK1 | 2.75957325 |
| 5 | NEK9 | 2.75315132 |
| 6 | ITK | 2.37055511 |
| 7 | TLK1 | 2.19927387 |
| 8 | STK24 | 2.02935563 |
| 9 | STK16 | 11.6400905 |
| 10 | FRK | 1.95252664 |
| 11 | GRK1 | 1.87664590 |
| 12 | AKT3 | 1.73639282 |
| 13 | NME1 | 1.73502929 |
| 14 | DDR2 | 1.63107759 |
| 15 | TXK | 1.48133326 |
| 16 | KDR | 1.40197532 |
| 17 | MAP4K2 | 1.32153112 |
| 18 | STK3 | 1.28866266 |
| 19 | MAPK7 | 1.14985958 |
| 20 | EIF2AK1 | 1.14794791 |
| 21 | CSK | 1.08098786 |
| 22 | TBK1 | 1.06790736 |
| 23 | PAK3 | 1.03645244 |
| 24 | TEC | 1.01247259 |
| 25 | PINK1 | 0.98960042 |
| 26 | WNK3 | 0.98699651 |
| 27 | CSNK1A1L | 0.97039512 |
| 28 | NEK1 | 0.95236758 |
| 29 | CSNK1G3 | 0.92850309 |
| 30 | GRK7 | 0.89473804 |
| 31 | ZAK | 0.83713568 |
| 32 | STK38L | 0.82494441 |
| 33 | ACVR1B | 0.75932928 |
| 34 | NUAK1 | 0.72962630 |
| 35 | PHKG2 | 0.72740311 |
| 36 | PHKG1 | 0.72740311 |
| 37 | BTK | 0.70091254 |
| 38 | CSNK1G2 | 0.69785472 |
| 39 | TSSK6 | 0.69294738 |
| 40 | MST4 | 0.67690995 |
| 41 | CASK | 0.67131051 |
| 42 | ADRBK1 | 0.63432815 |
| 43 | CSNK1G1 | 0.59776863 |
| 44 | LIMK1 | 0.58954543 |
| 45 | RPS6KB1 | 0.55677852 |
| 46 | CAMK2D | 0.54389301 |
| 47 | VRK1 | 0.52789067 |
| 48 | PIK3CA | 0.50625407 |
| 49 | BMPR1B | 0.49773475 |
| 50 | CAMK2A | 0.49590025 |
| 51 | IRAK1 | 0.49022962 |
| 52 | PTK2B | 0.46631784 |
| 53 | PLK4 | 0.44453711 |
| 54 | INSRR | 0.44450888 |
| 55 | OXSR1 | 0.43873642 |
| 56 | DAPK3 | 0.42890185 |
| 57 | BUB1 | 0.42107320 |
| 58 | PLK1 | 0.42095899 |
| 59 | STK39 | 0.41954325 |
| 60 | MAP2K6 | 0.41921741 |
| 61 | PRKCG | 0.40937521 |
| 62 | PRKCE | 0.40382815 |
| 63 | PLK3 | 0.39950726 |
| 64 | OBSCN | 0.39249410 |
| 65 | EGFR | 0.37489532 |
| 66 | LCK | 0.35637827 |
| 67 | CSNK2A2 | 0.35450904 |
| 68 | INSR | 0.35093162 |
| 69 | PRKG1 | 0.34871734 |
| 70 | DYRK2 | 0.34688755 |
| 71 | PLK2 | 0.33996688 |
| 72 | SYK | 0.33329824 |
| 73 | CSNK1A1 | 0.33300281 |
| 74 | PRKACA | 0.30801792 |
| 75 | EIF2AK3 | 0.29338479 |
| 76 | PRKCB | 0.29234032 |
| 77 | PRKCA | 0.28505312 |
| 78 | ATR | 0.27783347 |
| 79 | ROCK1 | 0.27298910 |
| 80 | MAPKAPK5 | 0.26441808 |
| 81 | CDK7 | 0.26244564 |
| 82 | STK4 | 0.25298296 |
| 83 | ERBB3 | 0.25248292 |
| 84 | CSNK2A1 | 0.23314616 |
| 85 | LYN | 0.22547033 |
| 86 | RPS6KB2 | 0.21694739 |
| 87 | PAK4 | 0.21465981 |
| 88 | CDK11A | 0.19760185 |
| 89 | PRKCQ | 0.19364607 |
| 90 | TIE1 | 0.19330264 |
| 91 | KIT | 0.19238785 |
| 92 | LATS1 | 0.19201287 |
| 93 | MAPK15 | 0.19149925 |
| 94 | TRIM28 | 0.17885332 |
| 95 | ERBB2 | 0.17876360 |
| 96 | CDK18 | 0.16985857 |
| 97 | AURKA | 0.16781948 |
| 98 | PASK | 0.15027356 |
| 99 | CDK15 | 0.14946865 |
| 100 | IGF1R | 0.14918976 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 4.47607967 |
| 2 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 3.99749010 |
| 3 | Protein export_Homo sapiens_hsa03060 | 2.97378395 |
| 4 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 2.58532571 |
| 5 | Ribosome_Homo sapiens_hsa03010 | 2.53048862 |
| 6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.45716543 |
| 7 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.22015558 |
| 8 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.17228839 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.86782588 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 1.82953776 |
| 11 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.79427228 |
| 12 | Parkinsons disease_Homo sapiens_hsa05012 | 1.75175009 |
| 13 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.74702858 |
| 14 | Histidine metabolism_Homo sapiens_hsa00340 | 1.71184578 |
| 15 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.68060212 |
| 16 | Proteasome_Homo sapiens_hsa03050 | 1.64746929 |
| 17 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.62725163 |
| 18 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.60995900 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 1.56377204 |
| 20 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.54524260 |
| 21 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.53954183 |
| 22 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.53042607 |
| 23 | Basal transcription factors_Homo sapiens_hsa03022 | 1.49327634 |
| 24 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.46309227 |
| 25 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.44115461 |
| 26 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.41654429 |
| 27 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.39656359 |
| 28 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.32068829 |
| 29 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.31793013 |
| 30 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.30054784 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.27679444 |
| 32 | RNA polymerase_Homo sapiens_hsa03020 | 1.26485511 |
| 33 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.26329403 |
| 34 | Purine metabolism_Homo sapiens_hsa00230 | 1.17870290 |
| 35 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.11805273 |
| 36 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.10415893 |
| 37 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.10167914 |
| 38 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.08251043 |
| 39 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.06886671 |
| 40 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.06786054 |
| 41 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.04496704 |
| 42 | Nicotine addiction_Homo sapiens_hsa05033 | 1.03591692 |
| 43 | Alzheimers disease_Homo sapiens_hsa05010 | 1.01874198 |
| 44 | Huntingtons disease_Homo sapiens_hsa05016 | 1.00737616 |
| 45 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.00339248 |
| 46 | Asthma_Homo sapiens_hsa05310 | 0.96503507 |
| 47 | Legionellosis_Homo sapiens_hsa05134 | 0.94903420 |
| 48 | Olfactory transduction_Homo sapiens_hsa04740 | 0.94728873 |
| 49 | Long-term depression_Homo sapiens_hsa04730 | 0.90226253 |
| 50 | Phototransduction_Homo sapiens_hsa04744 | 0.88157695 |
| 51 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.86815671 |
| 52 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.84473932 |
| 53 | Mineral absorption_Homo sapiens_hsa04978 | 0.82532356 |
| 54 | ABC transporters_Homo sapiens_hsa02010 | 0.80139351 |
| 55 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.77117896 |
| 56 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.77021551 |
| 57 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.72599850 |
| 58 | Retinol metabolism_Homo sapiens_hsa00830 | 0.72453631 |
| 59 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.72419077 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.72227595 |
| 61 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.71966343 |
| 62 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.71478065 |
| 63 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.70540028 |
| 64 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.68061700 |
| 65 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.66514859 |
| 66 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.65026499 |
| 67 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.62034610 |
| 68 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.61775929 |
| 69 | Spliceosome_Homo sapiens_hsa03040 | 0.60768429 |
| 70 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.59279018 |
| 71 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.59237771 |
| 72 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.58978615 |
| 73 | Base excision repair_Homo sapiens_hsa03410 | 0.58645089 |
| 74 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.58102602 |
| 75 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.56333724 |
| 76 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.55976213 |
| 77 | Measles_Homo sapiens_hsa05162 | 0.54485629 |
| 78 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.54167712 |
| 79 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.51640349 |
| 80 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.49443619 |
| 81 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.48779627 |
| 82 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.47732370 |
| 83 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.47726025 |
| 84 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46861202 |
| 85 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.46000583 |
| 86 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.45476024 |
| 87 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.43072872 |
| 88 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.42339723 |
| 89 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.41002153 |
| 90 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.37976739 |
| 91 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.37850378 |
| 92 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.37738011 |
| 93 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.36889483 |
| 94 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.35739563 |
| 95 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.35335944 |
| 96 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.33750629 |
| 97 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.33401010 |
| 98 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.33340363 |
| 99 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.31627212 |
| 100 | RNA transport_Homo sapiens_hsa03013 | 0.29693000 |

